What triggered the compliance review?

An administrative oversight related to share placement capacity calculations.

Did the company outline corrective actions?

Yes, governance enhancements and external advisory support were confirmed.

Does this affect company operations?

The issue relates to compliance processes rather than day-to-day operations.

Radiopharm Theranostics Responds to ASX Rule Compliance Review

2 min read | December 18, 2025 03:05 PM AEDT | By Sam

Google News:

Radiopharm Theranostics Responds to ASX Rule Compliance Review — Image source: Shutterstock

What Was the Compliance Issue?

The company identified an inadvertent non-compliance with ASX Listing Rule provisions governing placement capacity. The issue arose due to the inclusion oversight of milestone-related shares when calculating allowable placement limits. As a result, the company exceeded its available placement capacity during a previous capital raising process.

This technical breach affected the eligibility of certain issued shares for formal ratification under ASX rules.

How Is the Company Responding?

Radiopharm Theranostics has acknowledged the oversight and confirmed steps are being taken to strengthen internal processes. Planned actions include enhanced governance controls, improved internal awareness of listing requirements among relevant officers, and the engagement of external advisers to provide additional compliance oversight.

These measures are intended to reduce the likelihood of similar issues occurring in the future and to support alignment with regulatory expectations.

Why Governance Measures Matter

Strong governance frameworks are a core component of maintaining market confidence, particularly for companies operating in highly regulated sectors such as healthcare and biotechnology. Clear compliance processes help ensure transparency, accountability, and adherence to exchange standards.

By addressing the issue promptly and outlining corrective steps, the company aims to reinforce its commitment to best-practice governance.

Radiopharm Theranostics Limited operates within the biotechnology sector, focusing on the development of radiopharmaceutical products for diagnostic and therapeutic applications. The company’s work is centred on advancing precision medicine through targeted healthcare solutions.

Regulatory compliance remains a critical responsibility for listed entities. Radiopharm Theranostics’ response highlights the importance of continuous oversight and structured governance as companies navigate complex listing requirements and capital management activities.

Frequently Asked Questions

What triggered the compliance review?

An administrative oversight related to share placement capacity calculations.
Did the company outline corrective actions?

Yes, governance enhancements and external advisory support were confirmed.
Does this affect company operations?

The issue relates to compliance processes rather than day-to-day operations.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.